‘Blood Products and the SWIFT trial for traumatic haemorrhage’ with Jason Smith

In this session we will examine the bleeding patient in the tactical and combat environment. We will dig into some of the fundamental education that has changed practice in recent years, we will also examine the SWIFT Study which is a study of Whole blood In Frontline Trauma A multi-centre randomised controlled trial of the clinical and cost-effectiveness of pre-hospital whole blood administration versus standard care for traumatic haemorrhage. To do this I am speaking with Surgeon Capt Jason Smith. Jason is currently the Defence Professor of Emergency Medicine at the Academic Department of Military Emergency Medicine, Royal Centre for Defence Medicine, Birmingham. He was also appointed Royal College of Emergency Medicine Professor in 2013, and is an Honorary Professor at Plymouth University Peninsula Schools of Medicine and Dentistry. He was Consultant Advisor in Emergency Medicine to the Medical Director General (Navy) from 2010-2014. He is a Fellow of the Royal College of Emergency Medicine, the Royal College of Physicians of London, and the Royal Geographical Society. He undertook a doctorate in the management of patients with blast lung injury, and his current research interests include the treatment of pain in emergency patients and the management of traumatic cardiac arrest. In the episode we examine: Sequential approach to arresting bleeding The utility of TXA Pharmacological agents - TXA, FFP, FDP, blood, cryo-p, RePHILL The RePHILL trial Pain mx and preferential agents Freeze Dried Plasma and Fresh Frozen Plasma and part of the array of intervention The SWIFT trial To find more on the SWIFT trial please see here: https://www.nhsbt.nhs.uk/clinical-trials-unit/current-trials-and-studies/swift/ This podcast is brought to you in association with BHA Medical. BHA medical source, supply and implement innovative medical technology and solutions across the globe. BHA provide market leading services in covid 19 testing kits, medical products, smart technology and consultancy. One of the latest solutions that BHA medical offer is the iMed end-to-end Covid-19 testing and monitoring solution. NPH iMed is an end-to-end Covid-19 testing and monitoring solution, developed in partnership with BHA Medical Limited to assist in collating and managing test results, reopen travel, leisure, events and entertainment. One of the first independent online test verification systems in the world, NPH iMed is a leading solution for testing, managing and monitoring all of your Covid-19 needs. NPH Group has simplified the process of reporting test result data for you through our online platform which makes capturing the required data for submission easy, while easily recalling individuals for repeat testing and submissions. NPH have created a fully compliant and automatic upload capability, so you don’t have to worry about it, with a cost-effective solution. More can be found here: https://bha-medical.com https://www.bha-medical.com/imed-self-testing-monitoring-covid-19-app